ArticleMolecular psychiatry2025
Stress induces behavioral disorders by promoting microglial phagocytosis via decreasing neuronal Dkk3.
Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- GV-971 Ameliorates Chronic Restraint Stress-Induced Depression-like Phenotypes Accompanied by Reshaping of the Microbiota-Gut-Brain Axis.Marine drugs · 2026Article
- Identification and functional characterization of plasma exosomal miR-618 as a novel biomarker in recurrent depressive disorder.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Microglia play an important role in the central nervous system, particularly with regard to altering synaptic function. However, the exact function of these microglia in major depressive disorder (MDD) remains unclear. Here, we report that in a chronic unpredictable mild stress (CUMS) model of depression, the expression of Dkk3 protein, the dickkopf Wnt signaling pathway inhibitor 3, was downregulated in the cornu ammonis 1 (CA1) region of the hippocampus. Neuronal-specific knockdown of Dkk3 increased microglial activation and engulfment, thereby contributing to depressive- and anxiety-like behaviors, via the Wnt-CX3CL1/CX3CR1 signaling pathway. With the ablation of microglia or chemical inhibition of CA1 pyramidal neurons, depressive-like behaviors were abolished. Moreover, treatment with a CX3CL1 McAb or XAV-939, an inhibitor of the Wnt pathway, ameliorated CUMS-induced behavioral deficits and decreased microglial phagocytosis of neuronal spines. Taken together, these results demonstrate that Dkk3 plays a critical role in regulating microglial engulfment, an effect which induces long-lasting disruptions of CA1 neurons in response to stress. These findings reveal important new mechanistic insights into the potential for Dkk3 to exert a protective role against MDD pathogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.